Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice - Wikidata - wikimedia - TriplyDB

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

http://www.wikidata.org/entity/Q34097557

about

Current Landscape of Antiviral Drug Discovery Hepatitis B virus therapy: What's the future holding for us?New generation humanized mice for virus research: comparative aspects and future prospects Hepatitis B virus infection and immunopathogenesis in a humanized mouse model: induction of human-specific liver fibrosis and M2-like macrophages Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus Hepatitis B virus molecular biology and pathogenesis Emerging antivirals for the treatment of hepatitis B.Generation of improved humanized mouse models for human infectious diseases.Search for a cure for chronic hepatitis B infection: How close are we?High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein Humanized mice for immune system investigation: progress, promise and challenges Humanized mice for the study of infectious diseases.Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly.Chronic hepatitis C infection-induced liver fibrogenesis is associated with M2 macrophage activation.Liver immune-pathogenesis and therapy of human liver tropic virus infection in humanized mouse models.Treatment options beyond IFNα and NUCs for chronic HBV infection: expectations for tomorrow.Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants Eradication Strategies for Chronic Hepatitis B Infection.Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver.Targeted delivery of siRNA against hepatitis B virus by preS1 peptide molecular ligand.Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?

P2860

Q26766639-27C590B0-2E2A-4099-972C-DE0D61FD6BE6 Q26774198-E8A78C49-CE50-438C-B6CE-A9ABCD8DA4DC Q27014786-8D2CA0AF-E5D0-46BF-885E-7F501C1748F8 Q27329614-3A43A734-CE65-4A2B-A301-72C1A92D3851 Q28551711-03C9257A-8610-4E80-B645-2ABD7E311CD1 Q28818406-FA89C32C-A473-4CC1-90B8-43213B6570F9 Q33801328-3969F397-F42D-4F48-A723-E5943C8D2250 Q34135605-5DFDABD5-25DF-404A-8028-E1A97D2ECD1A Q35626790-0880BC04-C435-4730-A2E2-6E28F72C8046 Q36371517-EF92E22F-C18B-4AD8-B96A-E4B54B8944A3 Q37111994-11EA8E45-D76F-466B-B090-DFCCFDC75AFD Q37179146-A51D5645-8A0E-4223-980A-E7BE6B791D79 Q37263351-D8BB7DEB-E0AF-4875-ADFD-2BCD16270CCA Q37522434-E896469A-F479-41FF-8D68-031495D3847D Q37677390-352A78F9-C4ED-4B9B-8C18-67820A212C0E Q38255840-05BBB3F8-C94B-424B-AD9D-8DD37A195F1B Q38351585-96C7A523-A93B-4EAC-B047-D5C5A542BA08 Q38447283-FF244251-5656-4134-8479-0A99BB8AC102 Q38742110-638EBA08-3FAD-4315-A39F-77374B052E29 Q38755680-0977CB47-5E04-465A-BBDB-9C3C6769AD1D Q38837065-33D70C53-4231-48DF-9061-87EB63AC033D Q40066224-A2253E3E-DA71-4652-8F74-816944CBA28E Q42288252-4C38A6C6-64F7-4681-B158-168971D19A65 Q47136128-FD8C4CEE-1C9F-4864-9F5C-537E45119D6E

P2860

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

http://www.wikidata.org/entity/Q34097557

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@ast

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@en

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@nl

type

label

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@ast

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@en

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@nl

prefLabel

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@ast

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@en

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@nl

P1433

Q34097557-9E916B0A-0938-45AE-AE9C-46ADD595E75E

P1476

Q34097557-00DE1420-61BD-4AC5-918C-678758D0F7BC

P2093

Q34097557-0F98E0DF-6691-4497-A54E-01E307C5C2AE

Q34097557-281492C8-F755-4236-A569-FC6EDBFC4676

Q34097557-362C18AA-2FC5-46CB-9EFD-9AC068E240BE

Q34097557-36557A1F-4FB6-444C-A8EA-29EEAE90D914

Q34097557-3BE0EC57-72C4-409D-A494-6DC6FD78E4C0

Q34097557-87318251-CC76-4536-B4A3-13E4D312E0BF

Q34097557-93C1404E-0395-4AD9-8A81-47406944C209

Q34097557-970D892D-72AB-49C6-9343-4E6FB5A9193C

Q34097557-C492A134-E641-4F3B-929A-16678432B2EA

Q34097557-D0778C85-9CE6-4E47-9E0E-BF7652FD9406

P2860

Q34097557-006AA781-9304-4A9A-A9B6-1E0905A7B46A

Q34097557-00EC8A57-8CC1-4A1B-A5EE-D733195B3E8D

Q34097557-02C77BCE-C34B-4328-A4E0-F596557A2A8A

Q34097557-11109C8A-7D43-4303-A1E8-C340A9449649

Q34097557-252069BA-3A83-4DF5-AB76-EFAD70F2AE01

Q34097557-28172D6A-CAE0-484E-878F-ABA2B051C256

Q34097557-401BA315-57F9-4656-B1CE-78785EB8BB9E

Q34097557-49453561-69ED-4111-AF2E-E7C148ACADC2

Q34097557-4D811056-0299-435B-9C24-0CBAA4A1F94A

Q34097557-543CEDD0-E495-4350-AFA0-4FFA308BE1FA

P304

Q34097557-B5132B42-2877-45C1-AD3C-E7683DF18676

P31

Q34097557-89A8C5D6-EA2E-4A38-B7BA-6005E068172E

P356

Q34097557-4FF0DA48-9A86-41C7-AD19-40727E424C7C

P407

Q34097557-552B7BD9-8EB0-4322-8859-0B78E74E18B1

P433

Q34097557-F8E78646-C8C8-46EA-81EE-D03E7F0CD358

P478

Q34097557-EB25BF6E-3C74-430A-9FC6-15FA7AE1B761

P50

Q34097557-2C9D155E-A2CF-423B-85A9-A484FDD5BF25

Q34097557-6C5BF0FC-C0F8-48D2-9CB3-00A325372B96

Q34097557-B2E752D4-307A-4B73-9BDB-8E68D2C4DBA8

Q34097557-C55BD4CE-6911-4E30-A91E-03854728641F

Q34097557-C9EE5DCB-9BCC-4F90-85AA-1BF87AAE20C8

P577

Q34097557-82021767-09FE-40F4-80AC-D40DC7E3C908

P5875

Q34097557-8600B5A9-9414-4FA9-AAAD-70389364AFAC

P698

Q34097557-E9AC2559-A870-44D2-AEA8-21496B0CC3DF

P932

Q34097557-AF12D3AE-3782-462A-8C59-11E1B311B894

P356

JOURNAL.PONE.0025096

P1433

P1476

Antiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID mice

@en

P2093

Céline Lamant

http://www.w3.org/2001/XMLSchema#string

Eric Giang

http://www.w3.org/2001/XMLSchema#string

Eva Wimmer

http://www.w3.org/2001/XMLSchema#string

Gherard Puerstinger

http://www.w3.org/2001/XMLSchema#string

Hélène Massinet

http://www.w3.org/2001/XMLSchema#string

Jacques Belghiti

http://www.w3.org/2001/XMLSchema#string

Lucie DaSilva

http://www.w3.org/2001/XMLSchema#string

Marie-Noëlle Brunelle

http://www.w3.org/2001/XMLSchema#string

Nicolas Brezillon

http://www.w3.org/2001/XMLSchema#string

Serban Morosan

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis B: the virus and disease

NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats.

A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly

Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus

Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Antivirals interacting with hepatitis B virus core protein and core mutations may misdirect capsid assembly in a similar fashion.

Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera.

The alkylated imino sugar, n-(n-Nonyl)-deoxygalactonojirimycin, reduces the amount of hepatitis B virus nucleocapsid in tissue culture.

Hepatitis B: reflections on the current approach to antiviral therapy.

P304

e25096

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0025096

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Soussan

Laurent Hannoun

P577

2011-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51872256

http://www.w3.org/2001/XMLSchema#string

P698

22162746

http://www.w3.org/2001/XMLSchema#string

P932

3230577

http://www.w3.org/2001/XMLSchema#string